Home About us Editorial board Ahead of print Browse Articles Search Submit article Instructions Subscribe Contacts Login 
  • Users Online: 761
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Fenofibrate-induced renal dysfunction, yes or no?

Emami Fatemeh, Hariri Amirali, Matinfar Mohammad, Nematbakhsh Mehdi

Year : 2020| Volume: 25| Issue : 1 | Page no: 39-39

   This article has been cited by
1 Design, synthesis, and biological evaluation of a novel dual peroxisome proliferator-activated receptor alpha/delta agonist for the treatment of diabetic kidney disease through anti-inflammatory mechanisms
Kai Liu,Xing Zhao,Xue Qi,Dong-Liang Hou,Hao-Bin Li,Yu-Hao Gu,Qing-Long Xu
European Journal of Medicinal Chemistry. 2021; : 113388
[Pubmed]  [Google Scholar] [DOI]
2 PPARa Agonist Oral Therapy in Diabetic Retinopathy
Yohei Tomita,Deokho Lee,Kazuo Tsubota,Toshihide Kurihara
Biomedicines. 2020; 8(10): 433
[Pubmed]  [Google Scholar] [DOI]
3 Pemafibrate Protects Against Retinal Dysfunction in a Murine Model of Diabetic Retinopathy
Yohei Tomita,Deokho Lee,Yukihiro Miwa,Xiaoyan Jiang,Masayuki Ohta,Kazuo Tsubota,Toshihide Kurihara
International Journal of Molecular Sciences. 2020; 21(17): 6243
[Pubmed]  [Google Scholar] [DOI]


Read this article